Lipids in the development and treatment of human intestinal diseases - Lipids in intestinal diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015041

Enrollment

432

Registered

2018-07-10

Start date

2019-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K57 C18

Interventions

Group 1: Colon tissue (tumor, control tissue and tissue from diverticulitis patients) which is optained within a surgical intervention at the Asklepios Paulinen Clinic in Wiesbaden is directly transfe

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Colon tissue from patients with diverticulitis or colon tumors (at least with a size of 1cm³)

Exclusion criteria

Exclusion criteria: not clearly characterized tissue

Design outcomes

Primary

Measure	Time frame
Lipid level after stimulation and anti-inflammatory therapy	—

Secondary

Measure	Time frame
Activity of protein kinases, phosphatases after anti-inflammatory therapy, release of cytokines and cell proliferation	—

Countries

Germany

Contacts

Public ContactMartin Hoffmann

Chirurgischen Zentrums I, Allgemein- und ViszeralchirurgieAsklepios Paulinen Klinik,

mart.hoffmann@asklepios.com0611-847-2431

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026